BioVie, Inc. (BIVI)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Aug 28, 16:00
2.17
+0.01
(+0.46%)
After-Hours: 20:00
BioVie Total Liabilities (Quarterly) : 3.980M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.980M |
| March 31, 2026 | 1.907M |
| December 31, 2025 | 3.238M |
| September 30, 2025 | 1.899M |
| June 30, 2025 | 2.550M |
| March 31, 2025 | 2.842M |
| December 31, 2024 | 1.772M |
| September 30, 2024 | 7.171M |
| June 30, 2024 | 9.702M |
| March 31, 2024 | 12.85M |
| December 31, 2023 | 14.00M |
| September 30, 2023 | 16.21M |
| June 30, 2023 | 19.76M |
| March 31, 2023 | 23.46M |
| December 31, 2022 | 21.12M |
| September 30, 2022 | 16.90M |
| June 30, 2022 | 16.44M |
| March 31, 2022 | 16.23M |
| December 31, 2021 | 15.81M |
| September 30, 2021 | 1.744M |
| June 30, 2021 | 0.9964M |
| March 31, 2021 | 1.491M |
| December 31, 2020 | 0.3849M |
| September 30, 2020 | 0.2657M |
| June 30, 2020 | 23.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.654M |
| December 31, 2019 | 4.384M |
| September 30, 2019 | 11.33M |
| June 30, 2019 | 0.4435M |
| March 31, 2019 | 0.1791M |
| December 31, 2018 | 0.1048M |
| September 30, 2018 | 0.1831M |
| June 30, 2018 | 2.064M |
| March 31, 2018 | 1.660M |
| December 31, 2017 | 1.455M |
| September 30, 2017 | 1.241M |
| June 30, 2017 | 1.207M |
| March 31, 2017 | 0.9785M |
| December 31, 2016 | 1.151M |
| September 30, 2016 | 0.9614M |
| June 30, 2016 | 0.8032M |
| March 31, 2016 | 0.4447M |
| December 31, 2015 | 0.4043M |
| September 30, 2015 | 0.3728M |
| June 30, 2015 | 0.3236M |
| March 31, 2015 | 0.2832M |
| December 31, 2014 | 0.2472M |
| September 30, 2014 | 0.2036M |
| June 30, 2014 | 0.1615M |
| March 31, 2014 | 0.0025M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.25M |
| Shareholders Equity (Quarterly) | 10.27M |
| Debt to Equity Ratio | 0.0268 |
| Current Ratio | 3.594 |
| Net Debt Paydown Yield | 0.12% |